M. Rachchh, R. Gokani, Hetal Patel, Jainik Khamar, Apurva Patel
{"title":"在禁食的健康成人中单次口服大戟草胶囊与微姜黄素胶囊的生物利用度研究","authors":"M. Rachchh, R. Gokani, Hetal Patel, Jainik Khamar, Apurva Patel","doi":"10.29011/2577-2201.100091","DOIUrl":null,"url":null,"abstract":"Aim: The purpose of this study is to evaluate and compare the amount of free Curcumin in the human blood plasma after administration of three Capsules of Maxicuma 500 mg and three Capsules of Micronized Curcumin 95% each 500 mg as single dose in fasted healthy adult human subjects. The results of the study are also compared with plasma concentration of free Curcumin by Standard Curcumin as reported in the literature [17]. Methodology: Comparative bioavailability of free curcumin for three Capsules of Maxicuma 500 mg and three Capsules of Micronized Curcumin 95%, (500) mg was evaluated in an open label, non-randomized, two-treatment, two-period, two-group crossover study after single oral dose administration in 14 fasted healthy adult humans. The free Curcumin was determined along with pharmacokinetic parameters such as Cmax, AUC0-t, T1/2, Ke, Tmax, %AUC extra, n points, Ke_first and Ke_last. Linear & Semi log graphs were plotted with the help of SASR ® . In addition, the total Curcuminoids (Comprising Curcumin, Bis-Demethoxy curcumin, Demethoxy curcumin & Tetra hydrocurcumin) after reaction with mixture of glucuronidas3 + sulphatase enzyme was estimated in plasma using validated LC-MS-MS method. Results: Data from the study reveals that the maximum measured plasma concentration of free Curcumin was 195.196 ng/mL for Maxicuma and 81.270 ng/mL for Micronized Curcumin 95%. The times where maximum plasma concentration of free Curcumin achieved for the Maxicuma and Micronized Curcumin 95%, were 3.129 hours and 4.750 hours respectively. Conclusion: Maxicuma composition was 3.11 fold more bioavailable, in terms of free Curcumin level, as compared to Micronized Curcumin 95%. As it is known from the literature that, micronization enhances the bioavailability by 9 folds, one can conclude that Maxicuma was 66.47(3.11/0.4 x 0.95 x 9) times more bioavailable in terms of total Curcuminoids compared to Standard Curcumin extract powder 95% and based on the literature study, provides 172 times more bioactive free Curcumin when compared to Standard Curcumin 95%.","PeriodicalId":350008,"journal":{"name":"Current Research in Complementary & Alternative Medicine","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bioavailability Study of Maxicuma Capsules Versus Micronized Curcumin Capsules as A Single Oral Dose in Fasted Healthy Adult Human Subjects\",\"authors\":\"M. Rachchh, R. Gokani, Hetal Patel, Jainik Khamar, Apurva Patel\",\"doi\":\"10.29011/2577-2201.100091\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: The purpose of this study is to evaluate and compare the amount of free Curcumin in the human blood plasma after administration of three Capsules of Maxicuma 500 mg and three Capsules of Micronized Curcumin 95% each 500 mg as single dose in fasted healthy adult human subjects. The results of the study are also compared with plasma concentration of free Curcumin by Standard Curcumin as reported in the literature [17]. Methodology: Comparative bioavailability of free curcumin for three Capsules of Maxicuma 500 mg and three Capsules of Micronized Curcumin 95%, (500) mg was evaluated in an open label, non-randomized, two-treatment, two-period, two-group crossover study after single oral dose administration in 14 fasted healthy adult humans. The free Curcumin was determined along with pharmacokinetic parameters such as Cmax, AUC0-t, T1/2, Ke, Tmax, %AUC extra, n points, Ke_first and Ke_last. Linear & Semi log graphs were plotted with the help of SASR ® . In addition, the total Curcuminoids (Comprising Curcumin, Bis-Demethoxy curcumin, Demethoxy curcumin & Tetra hydrocurcumin) after reaction with mixture of glucuronidas3 + sulphatase enzyme was estimated in plasma using validated LC-MS-MS method. Results: Data from the study reveals that the maximum measured plasma concentration of free Curcumin was 195.196 ng/mL for Maxicuma and 81.270 ng/mL for Micronized Curcumin 95%. The times where maximum plasma concentration of free Curcumin achieved for the Maxicuma and Micronized Curcumin 95%, were 3.129 hours and 4.750 hours respectively. Conclusion: Maxicuma composition was 3.11 fold more bioavailable, in terms of free Curcumin level, as compared to Micronized Curcumin 95%. As it is known from the literature that, micronization enhances the bioavailability by 9 folds, one can conclude that Maxicuma was 66.47(3.11/0.4 x 0.95 x 9) times more bioavailable in terms of total Curcuminoids compared to Standard Curcumin extract powder 95% and based on the literature study, provides 172 times more bioactive free Curcumin when compared to Standard Curcumin 95%.\",\"PeriodicalId\":350008,\"journal\":{\"name\":\"Current Research in Complementary & Alternative Medicine\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Research in Complementary & Alternative Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29011/2577-2201.100091\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Research in Complementary & Alternative Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29011/2577-2201.100091","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:评价和比较空腹健康人单次服用三粒大黄草胶囊500 mg和三粒95%姜黄素微胶囊500 mg后血浆中游离姜黄素的含量。本研究结果还与文献报道的标准姜黄素血浆游离姜黄素浓度进行了比较[17]。方法:在一项开放标签、非随机、两疗程、两组交叉研究中,对14名禁食的健康成年人进行单次口服给药后,评估三种500 mg的大黄草胶囊和三种95% (500)mg的微细姜黄素胶囊的游离姜黄素的比较生物利用度。测定游离姜黄素的药动学参数为Cmax、AUC0-t、T1/2、Ke、Tmax、%AUC extra、n点、Ke_first和Ke_last。借助SASR®绘制线性和半对数图。此外,采用经验证的LC-MS-MS法测定血浆中姜黄素(包括姜黄素、双去甲氧基姜黄素、去甲氧基姜黄素和四氢姜黄素)与葡萄糖醛酸as3 +硫酸酶混合物反应后的总姜黄素含量。结果:研究结果表明,大戟草的血浆游离姜黄素浓度最高为195.196 ng/mL, 95%的姜黄素微粉的血药浓度最高为81.270 ng/mL。结果表明,大黄鱼和微细姜黄素达到95%的最大血浆游离姜黄素浓度分别为3.129 h和4.750 h。结论:莪术成分的游离姜黄素含量比微姜黄素含量高3.11倍,生物利用度为95%。从文献中得知,微粉化后的生物利用度提高了9倍,可以得出结论,与标准姜黄素提取粉95%相比,大黄草总姜黄素的生物利用度提高了66.47(3.11/0.4 x 0.95 x 9)倍,根据文献研究,大黄草提供的无生物活性姜黄素是标准姜黄素95%的172倍。
Bioavailability Study of Maxicuma Capsules Versus Micronized Curcumin Capsules as A Single Oral Dose in Fasted Healthy Adult Human Subjects
Aim: The purpose of this study is to evaluate and compare the amount of free Curcumin in the human blood plasma after administration of three Capsules of Maxicuma 500 mg and three Capsules of Micronized Curcumin 95% each 500 mg as single dose in fasted healthy adult human subjects. The results of the study are also compared with plasma concentration of free Curcumin by Standard Curcumin as reported in the literature [17]. Methodology: Comparative bioavailability of free curcumin for three Capsules of Maxicuma 500 mg and three Capsules of Micronized Curcumin 95%, (500) mg was evaluated in an open label, non-randomized, two-treatment, two-period, two-group crossover study after single oral dose administration in 14 fasted healthy adult humans. The free Curcumin was determined along with pharmacokinetic parameters such as Cmax, AUC0-t, T1/2, Ke, Tmax, %AUC extra, n points, Ke_first and Ke_last. Linear & Semi log graphs were plotted with the help of SASR ® . In addition, the total Curcuminoids (Comprising Curcumin, Bis-Demethoxy curcumin, Demethoxy curcumin & Tetra hydrocurcumin) after reaction with mixture of glucuronidas3 + sulphatase enzyme was estimated in plasma using validated LC-MS-MS method. Results: Data from the study reveals that the maximum measured plasma concentration of free Curcumin was 195.196 ng/mL for Maxicuma and 81.270 ng/mL for Micronized Curcumin 95%. The times where maximum plasma concentration of free Curcumin achieved for the Maxicuma and Micronized Curcumin 95%, were 3.129 hours and 4.750 hours respectively. Conclusion: Maxicuma composition was 3.11 fold more bioavailable, in terms of free Curcumin level, as compared to Micronized Curcumin 95%. As it is known from the literature that, micronization enhances the bioavailability by 9 folds, one can conclude that Maxicuma was 66.47(3.11/0.4 x 0.95 x 9) times more bioavailable in terms of total Curcuminoids compared to Standard Curcumin extract powder 95% and based on the literature study, provides 172 times more bioactive free Curcumin when compared to Standard Curcumin 95%.